Raymond James cuts Ionis Pharmaceuticals price target on slow launch
Covered in this story
Tracked from this story
Raymond James’s $54 target on $IONS is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
Raymond James’s track record →Analyst targets on Ionis Pharmaceuticals
- BMO Capital Markets: at $44.3 · target $66 by Oct 2027 · Outperform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IONS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ionis Pharmaceuticals →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.